Renovo Concepts, Inc. was established in 2017 to develop and commercialize a new therapeutic modality developed and researched at the Wake Forest University. MTR is intended for use in treating injuries to the brain, heart and spinal cord.
Wake Forest University has a robust patent estate and published preclinical studies based on MTR technology. Renovo Concepts holds the world-wide exclusive license to develop and commercialize MTR.